PartsTable
Technical Data Sheet
Download PDF

NDC00085-0933-10 — THEOPHYLLINE EXTENDED-RELEASE TA

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00085-0933-10: THEOPHYLLINE EXTENDED-RELEASE TA.

THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: SCHERING, primary_container_content_quantity: 1000.000 TABLETS, active_medicament_medicinal_strength: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE TABLETS 200MG 1000S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-070-0821, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00085-0933-10
NSN: 6505-01-070-0821
FSC: 6505 — Drugs and Biologicals
CAGE: 53300 — SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP (USA)
SPECIFICATIONS
special_featuresANHYDROUS
primary_container_typeBOTTLE
therapeutic_equivalentSCHERING
primary_container_content_quantity1000.000 TABLETS
active_medicament_medicinal_strength200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyTHEOPHYLLINE EXTENDED-RELEASE TABLETS 200MG 1000S BT
NSN6505-01-070-0821
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available THEOPHYLLINE EXTENDED-RELEASE TA TITLE COMPONENT PN NDC00085-0933-10 MFR THEOPHYLLINE EXTENDED-
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: SCHERING
•
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
•
PRIMARY CONTAINER TYPE: BOTTLE
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTSCHERING
PRIMARY CONTAINER CONTENT QUANTITY1000.000 TABLETS
PRIMARY CONTAINER TYPEBOTTLE
SPECIAL FEATURESANHYDROUS
PART NAME ASSIGNED BY CONTROLLING AGENCYTHEOPHYLLINE EXTENDED-RELEASE TABLETS 200MG 1000S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 2
THEO-DUR TABLETSReference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00258-3583-10Same NSN cross-reference
Same NSN cross-reference
Also cataloged under this NSN
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00085-0933-10?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00085-0933-10?
NDC00085-0933-10 is a THEOPHYLLINE EXTENDED-RELEASE TA.
What parts can replace NDC00085-0933-10?
There are 2 known substitutes for NDC00085-0933-10: THEO-DUR TABLETS, NDC00258-3583-10. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00085-0933-10?
NDC00085-0933-10 is cataloged in the U.S. Government catalog under NSN 6505-01-070-0821. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00085-0933-10